NCT03620786View on ClinicalTrials.gov

HIFU for Focal Ablation of Prostate Tissue: An Observational Study

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

September 26, 2018

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2028

Conditions
Prostate Cancer
Interventions
DEVICE

Sonablate HIFU device

In this study, we will be using the Sonablate 450 HIFU System. The Sonablate HIFU device was approved by the U.S. FDA for prostate tissue ablation in October, 2015. HIFU is an example of focal therapy, where the intervention involves targeting diseased areas of prostate tissue, while preserving healthy prostate tissue and minimizing damage to surrounding structures.

Trial Locations (1)

90095

RECRUITING

University of California, Los Angeles, Los Angeles

All Listed Sponsors
lead

University of California, Los Angeles

OTHER